Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Sales | 8,288 | 8,835 | 6,356 | 11,878 | 8,358 |
| Gross Profit | 8,280 | 8,830 | 6,370 | 11,870 | 8,350 |
| Operating Expenses | 10,960 | 10,720 | 11,630 | 11,180 | 9,270 |
| Operating Income | -2,672 | -1,885 | -5,274 | 698 | -912 |
| Other Income | 2 | -5 | 24 | -18 | -8 |
| Pre-tax Income | -2,670 | -1,890 | -5,250 | 680 | -920 |
| Net Income Continuous | -2,675 | -1,890 | -5,251 | 689 | -928 |
| Net Income | $-2,675 | $-1,890 | $-5,251 | $689 | $-928 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 |
| EBITDA(a) | $-1,762 | $-1,035 | $-4,174 | $1,568 | $-22 |